Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors

被引:62
作者
Buchardt, J
Schiodt, CB
Krog-Jensen, C
Delaissé, JM
Foged, NT
Meldal, M
机构
[1] Carlsberg Lab, Dept Chem, DK-2500 Valby, Denmark
[2] OsteoPro AS, DK-2730 Herlev, Denmark
来源
JOURNAL OF COMBINATORIAL CHEMISTRY | 2000年 / 2卷 / 06期
关键词
D O I
10.1021/cc000031q
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A solid phase combinatorial library of 165 000 phosphinic peptide inhibitors was prepared and screened for activity against MMP-12. The inhibitors of the library had the structure XXX-G Psi {PO2H-CH2}L-XXX, in which X is an arbitrary amino acid and G Psi {PO2H-CH2}L is a Gly-Leu phosphinic dipeptide analogue. The library was constructed as a one-bead-two-compounds library so that every bead contained a common quenched fluorogenic substrate and a different putative inhibitor. In addition, the inhibitor part was prepared by ladder synthesis. After incubation with MMP-12, beads containing active inhibitors were selected, and the inhibitor sequences were recorded using MALDI-TOF MS. Statistical analysis of the sequences obtained from 86 beads gave rise to a consensus sequence which was resynthesized along with 20 related sequences. Three truncated sequences and 16 sequences originally present on beads were also resynthesized. The inhibitors were investigated in an enzyme kinetic assay with MMP-12 showing that the compounds derived from the consensus sequence were strong inhibitors with Ki values down to 6 nM, whereas the sequences originally present on beads varied in potency with Ki values from micromolar to nanomolar. Truncated sequences derived from the consensus sequence were poor inhibitors of MMP-12.
引用
收藏
页码:624 / 638
页数:15
相关论文
共 46 条
  • [1] Auzanneau F I, 1995, J Pept Sci, V1, P31, DOI 10.1002/psc.310010106
  • [2] Molecular recognition of protein-ligand complexes: Applications to drug design
    Babine, RE
    Bender, SL
    [J]. CHEMICAL REVIEWS, 1997, 97 (05) : 1359 - 1472
  • [3] T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis
    Broddefalk, J
    Bäcklund, J
    Almqvist, F
    Johansson, M
    Holmdahl, R
    Kihlberg, J
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (31) : 7676 - 7683
  • [4] Buchardt J, 1999, CHEM-EUR J, V5, P2877, DOI 10.1002/(SICI)1521-3765(19991001)5:10<2877::AID-CHEM2877>3.0.CO
  • [5] 2-Z
  • [6] Phosphinic acid inhibitors of matrix metalloproteinases
    Caldwell, CG
    Sahoo, SP
    Polo, SA
    Eversole, RR
    Lanza, TJ
    Mills, SG
    Niedzwiecki, LM
    IzquierdoMartin, M
    Chang, BC
    Harrison, RK
    Kuo, DW
    Lin, TY
    Stein, RL
    Durette, PL
    Hagmann, WK
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (03) : 323 - 328
  • [7] Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides
    DelNery, E
    Juliano, MA
    Meldal, M
    Svendsen, I
    Scharfstein, J
    Walmsley, A
    Juliano, L
    [J]. BIOCHEMICAL JOURNAL, 1997, 323 : 427 - 433
  • [8] FERRERAS M, 1999, UNPUB
  • [9] GENERAL-METHOD FOR RAPID SYNTHESIS OF MULTICOMPONENT PEPTIDE MIXTURES
    FURKA, A
    SEBESTYEN, F
    ASGEDOM, M
    DIBO, G
    [J]. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1991, 37 (06): : 487 - 493
  • [10] Galardy RE, 1992, MATRIX, P259